Compare AGIO & GNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AGIO | GNL |
|---|---|---|
| Founded | 2007 | 2011 |
| Country | United States | United States |
| Employees | N/A | 56 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 2.0B |
| IPO Year | 2013 | N/A |
| Metric | AGIO | GNL |
|---|---|---|
| Price | $31.82 | $9.33 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 3 |
| Target Price | ★ $38.88 | $9.67 |
| AVG Volume (30 Days) | 856.4K | ★ 2.1M |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 7.98% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $43,011,000.00 | N/A |
| Revenue This Year | $76.75 | N/A |
| Revenue Next Year | $170.73 | $1.95 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $22.24 | $6.77 |
| 52 Week High | $46.00 | $10.04 |
| Indicator | AGIO | GNL |
|---|---|---|
| Relative Strength Index (RSI) | 62.62 | 47.94 |
| Support Level | $26.71 | $9.31 |
| Resistance Level | $36.07 | $9.65 |
| Average True Range (ATR) | 1.52 | 0.16 |
| MACD | 0.29 | 0.00 |
| Stochastic Oscillator | 97.47 | 35.92 |
Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.
Global Net Lease Inc is a real estate investment trust that manages a globally diversified portfolio of commercial real estate properties. The company is engaged in the ownership, management, operation, lease, acquisition, investment, and sale of the portfolio assets. Its segments include Industrial & Distribution, Retail, and Office. The company derives maximum revenue from the Industrial and Distribution segment. The company geographically operates in the United States, the United Kingdom, Canada, and Europe.